For investors & institutional partners

Invest in the neonatal blood gas app built at the bedside

NewIQ gives NICU and Labor & Delivery teams instant, newborn-specific blood gas interpretation at the point of care. It is live on iOS and Android today, and we are inviting hospital systems, healthcare institutions and investors to help put it in the hands of every clinician who cares for newborns.

  • Live on the App Store & Google Play

  • Zero PHI: session-only, on-device

  • Built by a nurse with ~30 years at the bedside

The clinical challenge

In high-acuity neonatal settings, seconds matter

Labor & Delivery nurses, NICU staff, respiratory therapists and neonatal transport teams routinely face complex blood gas interpretation decisions under pressure, often without fast, reliable reference tools at hand.

The result is cognitive burden, delayed decision-making and variability in practice, particularly among newer staff or during high-census periods. Printed reference cards, binders and desktop software were never designed for the speed and mobility modern bedside care demands.

NewIQ closes that gap: instant access to newborn-specific blood gas reference values, plain-language interpretation and workflow support, directly at the point of care.

Key benefits

What NewIQ delivers for an institution

Clinical efficiency

Immediate mobile access to neonatal reference values and interpretation support. Less time hunting for resources during high-acuity events, smoother workflows for nurses, RTs, NNPs and physicians.

Staff education & onboarding

Accelerates orientation for new nurses, residents and fellows, reinforces consistent interpretation standards across teams, and supports continuing education and competency development.

Patient safety & standardization

Promotes consistent, evidence-aligned neonatal blood gas interpretation and reduces cognitive burden during critical clinical moments, shaped by frontline clinical leadership.

Privacy & compliance

No patient data storage: zero PHI collected or transmitted. Everything a user enters is processed locally on the device, a privacy-first architecture designed with institutional risk in mind.

The opportunity

A shipped product in an underserved market

For venture and institutional investors, NewIQ pairs a working, shipped product with a clear route into hospital systems. The case in brief:

  • 01

    Shipped, not promised

    NewIQ is live today on the Apple App Store and Google Play as a paid app: a working product with practicing clinician users, not a prototype or a pitch deck.

  • 02

    An everyday clinical need

    Blood gases are interpreted around the clock in every NICU, Labor & Delivery unit and neonatal transport program, and many teams still reach for laminated cards and binders.

  • 03

    Two ways to grow

    Direct app-store sales today, institutional licensing next: department-wide and system-wide agreements, 30-day pilots, and custom enterprise deployments across large health systems.

  • 04

    Founder-market fit

    Built by a Labor & Delivery nurse with nearly 30 years at the bedside: the clinical credibility that makes hospital buyers and bedside users take the product seriously.

  • 05

    Procurement-friendly by design

    No PHI is collected, stored or transmitted, so institutional security and compliance review is far simpler than for connected clinical software.

Where it fits

Built for every team that cares for newborns

NewIQ is well suited for deployment across a broad range of clinical settings and teams:

Clinical departments

  • NICU

  • Labor & Delivery

  • Neonatal resuscitation teams

  • Respiratory therapy

  • Neonatal transport

Staff & teams

  • Bedside RNs & charge nurses

  • Respiratory therapists

  • Neonatal nurse practitioners

  • Residents & fellows

  • Nursing education programs

Ways to work together

Partnership & implementation options

We are actively seeking institutional partners and are prepared to structure an arrangement that fits your system's size, goals and budget. Options include:

  • Department-wide or system-wide staff licensing

  • Pilot program evaluation: a 30-day departmental pilot is the recommended starting point

  • Integration into nursing orientation and onboarding curricula

  • Educational program partnerships

  • Custom enterprise licensing for large health systems

Ready to scope one of these for your system? Start the conversation.

Clinical voices

What clinicians are saying

NewIQ provides clear, structured interpretations that align with neonatal practice, helpful for trainees and busy clinicians alike. An excellent support tool that improves confidence and speed when interpreting complex newborn blood gas results. Highly recommended for anyone working in NICU or newborn care.

Diane Brace, FNP-BC

Providence Willamette Falls Hospital

I've found NewIQ to be a convenient and valuable tool for interpreting neonatal blood gases. Having quick, easy access to blood gas interpretation in a user-friendly format is incredibly helpful for nurses and providers caring for newborns, and supports timely clinical decision-making.

Sarah Amar, BSN, RNC-OB

Providence Willamette Falls Birthplace

Sabrina Sabri, BSN, RNC-OB
Behind the app

Sabrina Sabri, BSN, RNC-OB

Founder, NewIQ · Sabrina Delivers Joy, LLC

Sabrina has spent nearly 30 years at the bedside in Labor & Delivery. She built NewIQ because neonatal blood gases deserve a neonatal reference, one a nurse can reach for in the moment it matters.

Next steps

Bring NewIQ to your teams

We would welcome the opportunity to meet with your clinical, administrative or investment leadership for a brief demonstration and a conversation about how NewIQ can support your goals, by phone, video or an on-site visit.

Sabrina Sabri, BSN, RN · CEO & Founder, Sabrina Delivers Joy, LLC